» Articles » PMID: 27441648

Assessing Progress, Impact, and Next Steps in Rolling Out Voluntary Medical Male Circumcision for HIV Prevention in 14 Priority Countries in Eastern and Southern Africa Through 2014

Overview
Journal PLoS One
Date 2016 Jul 22
PMID 27441648
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In 2007, the World Health Organization and the Joint United Nations Programme on HIV/AIDS (UNAIDS) identified 14 priority countries across eastern and southern Africa for scaling up voluntary medical male circumcision (VMMC) services. Several years into this effort, we reflect on progress.

Methods: Using the Decision Makers' Program Planning Tool (DMPPT) 2.1, we assessed age-specific impact, cost-effectiveness, and coverage attributable to circumcisions performed through 2014. We also compared impact of actual progress to that of achieving 80% coverage among men ages 15-49 in 12 VMMC priority countries and Nyanza Province, Kenya. We populated the models with age-disaggregated VMMC service statistics and with population, mortality, and HIV incidence and prevalence projections exported from country-specific Spectrum/Goals files. We assumed each country achieved UNAIDS' 90-90-90 treatment targets.

Results: More than 9 million VMMCs were conducted through 2014: 43% of the estimated 20.9 million VMMCs required to reach 80% coverage by the end of 2015. The model assumed each country reaches the UNAIDS targets, and projected that VMMCs conducted through 2014 will avert 240,000 infections by the end of 2025, compared to 1.1 million if each country had reached 80% coverage by the end of 2015. The median estimated cost per HIV infection averted was $4,400. Nyanza Province in Kenya, the 11 priority regions in Tanzania, and Uganda have reached or are approaching MC coverage targets among males ages 15-24, while coverage in other age groups is lower. Across all countries modeled, more than half of the projected HIV infections averted were attributable to circumcising 10- to 19-year-olds.

Conclusions: The priority countries have made considerable progress in VMMC scale-up, and VMMC remains a cost-effective strategy for epidemic impact, even assuming near-universal HIV diagnosis, treatment coverage, and viral suppression. Examining circumcision coverage by five-year age groups will inform countries' decisions about next steps.

Citing Articles

Evidence Gaps in Economic Evaluations of HIV Interventions Targeting Young People: A Systematic Review.

Zimmerman A, Fawole A, Shahid M, Dow D, Ogbuoji O J Adolesc Health. 2024; 75(5):709-724.

PMID: 39140926 PMC: 11490367. DOI: 10.1016/j.jadohealth.2024.06.013.


Fast-track interventions for HIV and AIDS epidemic control among key populations: A rapid review.

Luvuno Z, Wiafe E, Mpofana N, Urusla M, Nxumalo C Afr J Prim Health Care Fam Med. 2024; 16(1):e1-e12.

PMID: 38708735 PMC: 11079388. DOI: 10.4102/phcfm.v16i1.4088.


Preventing HIV Among Adolescent Boys and Young Men Through PEPFAR-Supported Voluntary Medical Male Circumcision in 15 Sub-Saharan African Countries, 2018-2021.

Peck M, Ong K, Lucas T, Thomas A, Wandira R, Ntwaaga B AIDS Educ Prev. 2023; 35:67-81.

PMID: 37406146 PMC: 11002756. DOI: 10.1521/aeap.2023.35.suppA.67.


Understanding the Evolving Role of Voluntary Medical Male Circumcision as a Public Health Strategy in Eastern and Southern Africa: Opportunities and Challenges.

Bershteyn A, Mudimu E, Platais I, Mwalili S, Zulu J, Mwanza W Curr HIV/AIDS Rep. 2022; 19(6):526-536.

PMID: 36459306 PMC: 9759505. DOI: 10.1007/s11904-022-00639-5.


Evaluation of factors associated with medical male circumcision in South Africa: A case-control study.

Okhue S, Mash R Afr J Prim Health Care Fam Med. 2022; 14(1):e1-e9.

PMID: 36331198 PMC: 9634705. DOI: 10.4102/phcfm.v14i1.3500.


References
1.
Thomas A, Tran B, Cranston M, Brown M, Kumar R, Tlelai M . Voluntary medical male circumcision: a cross-sectional study comparing circumcision self-report and physical examination findings in Lesotho. PLoS One. 2011; 6(11):e27561. PMC: 3226626. DOI: 10.1371/journal.pone.0027561. View

2.
Gopalappa C, Stover J, Shaffer N, Mahy M . The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIV. AIDS. 2014; 28 Suppl 1:S5-14. DOI: 10.1097/QAD.0000000000000083. View

3.
Njeuhmeli E, Stegman P, Kripke K, Mugurungi O, Ncube G, Xaba S . Modeling Costs and Impacts of Introducing Early Infant Male Circumcision for Long-Term Sustainability of the Voluntary Medical Male Circumcision Program. PLoS One. 2016; 11(7):e0159167. PMC: 4943713. DOI: 10.1371/journal.pone.0159167. View

4.
Meyer-Rath G, Brennan A, Fox M, Modisenyane T, Tshabangu N, Mohapi L . Rates and cost of hospitalization before and after initiation of antiretroviral therapy in urban and rural settings in South Africa. J Acquir Immune Defic Syndr. 2012; 62(3):322-328. PMC: 3625673. DOI: 10.1097/QAI.0b013e31827e8785. View

5.
Kripke K, Okello V, Maziya V, Benzerga W, Mirira M, Gold E . Voluntary Medical Male Circumcision for HIV Prevention in Swaziland: Modeling the Impact of Age Targeting. PLoS One. 2016; 11(7):e0156776. PMC: 4943626. DOI: 10.1371/journal.pone.0156776. View